Ipamorelin vs CJC-1295
Ipamorelin and CJC-1295 act on complementary pathways to stimulate growth hormone release. In Australian practice they are almost always prescribed together as a 1:1 compounded blend under TGA SAS-B.
Ipamorelin vs CJC-1295 — head to head
| Attribute | Ipamorelin | CJC-1295 |
|---|---|---|
| Class | Selective ghrelin-receptor agonist (pentapeptide) | GHRH analogue (long-acting) |
| GH pulse effect | Increases pulse frequency | Increases pulse amplitude |
| Cortisol / prolactin | Minimal impact | Minimal impact |
| Typical use | Component of GH blend, sometimes standalone | Almost always blended with Ipamorelin |
| AUD cost / month | ~$200–$340 standalone | Usually quoted as part of 1:1 blend ($220–$380) |
| AU legal pathway | TGA SAS-B | TGA SAS-B |
Verdict
Used standalone, Ipamorelin offers selective ghrelin-receptor stimulation; CJC-1295 offers GHRH-analogue support. The combination produces a stronger pulsatile GH response than either alone — which is why Australian compounding pharmacies most often dispense the 1:1 blend.
Frequently asked questions
- Should I take Ipamorelin alone or with CJC-1295?
- In Australian practice the 1:1 blend with CJC-1295 is more common because the two peptides act on complementary pathways and produce a stronger GH pulse together than either alone.
- Is the CJC-1295 + Ipamorelin blend legal in Australia?
- Yes — when prescribed by an AHPRA-registered Australian doctor under TGA SAS-B and compounded by a TGA-licensed Australian pharmacy. Buying it from offshore vendors is not legal.
Read the full profiles
Other comparisons
Be assessed by an Australian doctor
Take the free 5-minute intake. An AHPRA-registered Australian doctor will review your case and discuss the right molecule and pathway for you.
Start free assessment All peptides